Since its inception in 2016, the fund has achieved the following 
  • Over 54% of eligible Quad faculty applied
  • Reviewed 231 grant proposals
  • Q-FASTR awardees had 7 new start-up companies and close to $349 million in follow-on funding, which corresponds to over 20 times our investment

New Request for Proposals

Release date: Tuesday, December 2, 2025

Pre-proposal due: Tuesday, March 3, 2026

Full proposal due: Tuesday, May 5, 2026

Funding start date: Wednesday, July 1, 2026

Q-FASTR is dedicated to transforming cutting-edge basic research at HMS into tomorrow’s therapeutics, diagnostics, and related technologies. By championing early ideas and enveloping them with financial and scientific support, we cultivate breakthroughs that have the potential to reshape medicine.

Ifat Rubin-Bejerano
Senior Director, Translational Research Programs, Harvard Medical School